Imaging Technology News - November/December 2008 - (Page 32)

Imaging TECHNOLOGY Navilyst Introduces New Contrast Injection Products Navilyst Medical launched two new devices, an enhanced PICC Convenience Kitting and a new Xcela Power Injectable Port catheter for long-term delivery of fluids and medications, including chemotherapy; and a new EZ Huber Safety Infusion Set offers a dual-action safety mechanism designed to reduce the risk of bloodborne pathogen exposure. The new products premiered at the Annual Scientific Meeting of the Association for Vascular Access (AVA). The products provide clinicians and hospitals the catheter and accessory choices they require for a procedure that is efficient and conducive to reducing the risk of accidental needlesticks (OSHA) and infections (CDC and Joint Commission). Navilyst Medical | www.navilystmedical.com DR Software Upgrade Enhances Image Processing Connecticut Outpatient Center Discovers Expedience, Efﬁciency Using Kubtec Imager New software for Carestream Health’s DR 7500 digital radiography system is designed to deliver greater user control over image display, more consistent presentation of images across soft copy and hard copy devices and enhanced image processing algorithms. The new software contains KODAK DIRECTVIEW EVP Plus, engineered to provide more consistent image presentation and orthogonal control of image processing. This algorithm is said to enable simple and independent control of brightness, latitude, detail contrast and other parameters. In addition, a new tool available with EVP Plus allows for images to be calibrated to radiologist preferences to optimize image presentation and reduce the need for reprocessing. The software also supports body parts and projections. Carestream Health www.carestreamhealth.com “We wanted ease of use, we wanted prompt service, and image quality had to be top of the line,” FDA Approves EOVIST to Detect Liver Lesions The FDA recently cleared Bayer HealthCare Pharmaceuticals’ EOVIST (Gadoxetate Disodium) Injection, a gadolinium-based contrast agent, for intravenous use in T1weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease. EOVIST is a paramagnetic MRI contrast agent that combines features of both an extracellular contrast agent and a hepatocyte-specific agent. EOVIST is administered via an intravenous, bolus injection and has a dual route of excretion with approximately 50 percent eliminated through the liver and 50 percent eliminated through the kidney. Detection and characterization of malignant and benign focal liver lesions with EOVIST aims to help enhance diagnostic accuracy and increase diagnostic confidence. Bayer HealthCare Pharmaceuticals www.pharma.bayer.com “The image quality is great.” “We know the unit will be up and running, that the radiologists and surgeons are happy with the image quality, and that our techs are happy because the unit is easy to learn and use, and we haven’t had one malfunction or mechanical problem. I would recommend the XPERT to anyone.” Beth Ann Vara Chief Administrator of Ambulatory Imaging Caren Greenstein MD Director of Breast Imaging Contact Us 32 | ITN | Nov/Dec 2008 http://www.navilystmedical.com http://www.carestreamhealth.com http://www.pharma.bayer.com http://www.kubtec.com

Table of Contents Feed for the Digital Edition of Image Technology News - November 2008

Image Technology News - November 2008 Contents RSNA CT Systems Imaging An Image is Worth a Thousand Words Ultrasound Systems MBI Takes on FFDM Trouble in Multi-PACS Paradise When is Appropriateness Criteria Appropriate? RIS/PACS in a Web 2.0 World Digital Mammography Helps Center Continue its Commitment to the Best in Patient-Focused Breast Cancer Cardiovascular Imaging Systems PARCA Extends Expertise to World PACS Market

Image Technology News - November 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.